Assura Plc (LON:AGR - Get Free Report) insider Jayne Cottam sold 1,017,587 shares of the stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of GBX 50, for a total value of £508,793.50.
Jayne Cottam also recently made the following trade(s):
- On Tuesday, August 12th, Jayne Cottam sold 902,389 shares of Assura stock. The shares were sold at an average price of GBX 50, for a total value of £451,194.50.
- On Tuesday, August 5th, Jayne Cottam purchased 663 shares of Assura stock. The stock was bought at an average cost of GBX 49 per share, with a total value of £324.87.
- On Tuesday, July 22nd, Jayne Cottam sold 94,230 shares of Assura stock. The shares were sold at an average price of GBX 50, for a total value of £47,115.
- On Wednesday, July 9th, Jayne Cottam purchased 607 shares of Assura stock. The stock was bought at an average cost of GBX 50 per share, with a total value of £303.50.
Assura Stock Up 0.7%
LON AGR traded up GBX 0.34 on Tuesday, reaching GBX 48.04. The company had a trading volume of 21,986,264 shares, compared to its average volume of 28,930,729. The stock has a market capitalization of £1.56 billion, a P/E ratio of -45.92, a P/E/G ratio of 3.60 and a beta of 0.37. The company's fifty day moving average is GBX 49.78 and its 200 day moving average is GBX 47.25. Assura Plc has a 52-week low of GBX 35.24 and a 52-week high of GBX 50.95. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05.
Assura (LON:AGR - Get Free Report) last released its quarterly earnings results on Monday, July 21st. The real estate investment trust reported GBX 3.50 EPS for the quarter. Assura had a negative return on equity of 1.92% and a negative net margin of 18.09%. Sell-side analysts anticipate that Assura Plc will post 3.5830389 earnings per share for the current fiscal year.
About Assura
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
Read More

Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.